UCSF graduate student Bryan Faust examines a 3D representation of a COVID-19 spike particle, created using a cryo-electron microscope.
As COVID-19 hit and UCSF labs shut down, the Manglik and Walter labs got to work using nanobodies (camelid-derived antibodies) to counter the SARS-CoV-2 spike protein. Biophysics student Bryan Faust is one of the co-first authors on the resulting study.
The antiviral invented by Aashish Manglik, PhD, and colleagues is effective at blocking SARS-CoV-2 infection even as an aerosolized spray, according to laboratory testing.
School scientists developed an antiviral that fights SARS-CoV-2 that can be given as a nasal spray
